Int J Angiol 2015; 24(02): 133-136
DOI: 10.1055/s-0035-1547449
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Comparison of Angioseal and Manual Compression in Patients Undergoing Transfemoral Coronary and Peripheral Vascular Interventional Procedures

Abdullah M. Alshehri
1   Division of Cardiology, Department of Internal Medicine, University of Dammam, Saudi Arabia
,
Mohamed Elsharawy
2   Division of Vascular Surgery, Department of General Surgery, University of Dammam, Saudi Arabia
› Author Affiliations
Further Information

Publication History

Publication Date:
23 March 2015 (online)

Abstract

Vascular closure devices (VCDs) were introduced in the early 1990s with the goal of limiting the time, labor, bed rest, and patient discomfort associated with manual compression (MC) for hemostasis after cardiovascular interventions. However, its advantage over MC has not been extensively studied after interventional procedures. The aim of this study was to do prospective, randomized study comparing the safety and efficacy of the Angio-Seal (AS) to that of MC in patients undergoing transfemoral coronary and peripheral vascular interventional procedure.

A prospective, randomized trial was undertaken on consecutive series of patients admitted to King Fahd Hospital of the University for transfemoral coronary and peripheral vascular interventional procedures over 1 year. The study was designed to compare the hemostasis time in minutes and the incidence of vascular complications in patients receiving AS with those undergoing MC. All patients were on antiplatelets and received heparin during the procedure.

During the study period, 160 patients were included, 80 in each group. There was a significant difference in mean time to hemostasis in minutes (15.83 ± 1.63 minutes for MC and 0.42 ± 0.04 minutes for the AS; p < 0.001), time to ambulation in minutes (280 ± 15 for MC and 120 for AS; p = 0.04) and in minor complications (33.8% in MC vs. AS 5%; p < 0.001). However, the major complication rate did not significantly differ between the two groups (0% in AS vs. 2.5% in MC; p = 0.15).

AS was found to achieve rapid closure of the femoral access site safely in patients undergoing coronary and peripheral vascular interventional procedures under antiplatelets and systemic heparinization.

Note

This article was presented at the 6th Annual joint Meeting of ISES & MEET, June 2013, Rome, Italy.


 
  • References

  • 1 Dauerman HL, Applegate RJ, Cohen DJ. Vascular closure devices: the second decade. J Am Coll Cardiol 2007; 50 (17) 1617-1626
  • 2 Behan MW, Large JK, Patel NR, Lloyd GW, Sulke AN. A randomised controlled trial comparing the routine use of an Angio-Seal STS device strategy with conventional femoral haemostasis methods in a district general hospital. Int J Clin Pract 2007; 61 (3) 367-372
  • 3 Kolluri R, Fowler B, Nandish S. Vascular access complications: diagnosis and management. Curr Treat Options Cardiovasc Med 2013; 15 (2) 173-187
  • 4 Boztosun B, Günes Y, Yildiz A , et al. Early ambulation after diagnostic heart catheterization. Angiology 2007; 58 (6) 743-746
  • 5 Doyle BJ, Konz BA, Lennon RJ, Bresnahan JF, Rihal CS, Ting HH. Ambulation 1 hour after diagnostic cardiac catheterization: a prospective study of 1009 procedures. Mayo Clin Proc 2006; 81 (12) 1537-1540
  • 6 Hermiller J, Simonton C, Hinohara T , et al. Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization. J Invasive Cardiol 2005; 17 (10) 504-510
  • 7 Ratnam LA, Raja J, Munneke GJ, Morgan RA, Belli AM. Prospective nonrandomized trial of manual compression and Angio-Seal and Starclose arterial closure devices in common femoral punctures. Cardiovasc Intervent Radiol 2007; 30 (2) 182-188
  • 8 Upponi SS, Ganeshan AG, Warakaulle DR, Phillips-Hughes J, Boardman P, Uberoi R. Angioseal versus manual compression for haemostasis following peripheral vascular diagnostic and interventional procedures—a randomized controlled trial. Eur J Radiol 2007; 61 (2) 332-334
  • 9 Veasey RA, Large JK, Silberbauer J , et al. A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital—the SCOAST study. Int J Clin Pract 2008; 62 (6) 912-918
  • 10 Macdonald S, Thomas SM, Cleveland TJ, Gaines PA. Outpatient vascular intervention: a two-year experience. Cardiovasc Intervent Radiol 2002; 25 (5) 403-412
  • 11 Lucatelli P, Fanelli F, Cannavale A , et al. Angioseal VIP® vs. Starclose SE® closure devices: a comparative analysis in non-cardiological procedures. J Cardiovasc Surg (Torino) 2013; (e-pub ahead of print)
  • 12 Larsen EN, Hansen CB, Thayssen P, Jensen LO. Immediate mobilization after coronary angiography or percutaneous coronary intervention following hemostasis with the AngioSeal vascular closure device (the MOBS study). Eur J Cardiovasc Nurs 2013; 13 (5) 466-472
  • 13 Angio-Seal Vascular Closure Device. Instructions for use. 2010. Available at: www.sjmproffesional.com
  • 14 Piper WD, Malenka DJ, Ryan Jr TJ , et al; Northern New England Cardiovascular Disease Study Group. Predicting vascular complications in percutaneous coronary interventions. Am Heart J 2003; 145 (6) 1022-1029
  • 15 Applegate RJ, Sacrinty M, Kutcher MA , et al. Vascular complications with newer generations of angioseal vascular closure devices. J Interv Cardiol 2006; 19 (1) 67-74
  • 16 Kara K, Mahabadi AA, Berg MH , et al. Utilization of collagen-based vascular closure devices in patients with severe peripheral artery disease. J Invasive Cardiol 2013; 25 (1) 19-22
  • 17 Silber S. Hemostasis success rates and local complications with collagen after femoral access for cardiac catheterization: analysis of 6007 published patients. Am Heart J 1998; 135 (1) 152-156
  • 18 Gupta A, Sadiq I, Borer S. Distal embolization from Mynx device. Conn Med 2012; 76 (9) 545-548
  • 19 Khaldi A, Waldau B, Skowlund C, Velat GJ, Mocco J, Hoh BL. Delayed complication from a percutaneous vascular closure device following a neuro-interventional procedure. Interv Neuroradiol 2011; 17 (4) 495-500
  • 20 Durack JC, Thor Johnson D, Fidelman N, Kerlan RK, LaBerge JM. Entrapment of the StarClose Vascular Closure System after attempted common femoral artery deployment. Cardiovasc Intervent Radiol 2012; 35 (4) 942-944
  • 21 Cianci C, Kowal RC, Feghali G, Hohmann S, Stoler RC, Choi JW. Critical lower limb ischemia from an embolized Angio-Seal closure device. Proc (Bayl Univ Med Cent) 2013; 26 (4) 398-400
  • 22 Kara K, Kahlert P, Mahabadi AA , et al. Comparison of collagen-based vascular closure devices in patients with vs. without severe peripheral artery disease. J Endovasc Ther 2014; 21 (1) 79-84
  • 23 McDonald JS, Kallmes DF, Lanzino G, Cloft HJ. Percutaneous closure devices do not reduce the risk of major access site complications in patients undergoing elective carotid stent placement. J Vasc Interv Radiol 2013; 24 (7) 1057-1062
  • 24 Gurm HS, Hosman C, Share D, Moscucci M, Hansen BB ; Blue Cross Blue Shield of Michigan Cardiovascular Consortium. Comparative safety of vascular closure devices and manual closure among patients having percutaneous coronary intervention. Ann Intern Med 2013; 159 (10) 660-666
  • 25 Gregory D, Midodzi W, Pearce N. Complications with Angio-Seal™ vascular closure devices compared with manual compression after diagnostic cardiac catheterization and percutaneous coronary intervention. J Interv Cardiol 2013; 26 (6) 630-638
  • 26 Das R, Ahmed K, Athanasiou T, Morgan RA, Belli AM. Arterial closure devices versus manual compression for femoral haemostasis in interventional radiological procedures: a systematic review and meta-analysis. Cardiovasc Intervent Radiol 2011; 34 (4) 723-738